OptiBiotix Health books first-half loss as it inks more distribution pacts

Writer, Stock Market Wire
Wednesday, August 28, 2019 - 08:01

Dietry supplement group for weight loss and cholesterol control OptiBiotix Health booked a first-half loss after modest sales were offset by administrative costs.

Pre-tax losses for the six months through May amounted to £1.26m, compared to losses of £1.19m on-year.

Revenue rose to around £149k, up from around £81k on-year.

'This has been an exciting half year period, with twelve commercial deals signed, six for SlimBiome and six for LP-LDL, making a total of 44 deals since mid-2017,' chief executive Stephen O'Hara said.

'The large number of agreements signed in the last two years demonstrate early commercial progress.'

'The next stage of the process is to ensure these agreements deliver recurring revenue streams to build sales growth in 2019 against a continued low-cost base and create profitable divisions across all areas of the company.'

At 8:01am: (LON:OPTI) Optibiotix Health Plc share price was -5p at 61p

Related content

OptiBiotix Health gets key validation for probiotic product

OptiBiotix Health said subsidiary ProBiotix Health had completed process validation under pharmaceutical good manufacturing practices for its probiotic product as a drug substance.

The company...

Wed, 09/10/2019 - 07:33

OptiBiotix Health inks distribution pact for South Africa, neighbouring countries

OptiBiotix Health said it had entered into a one-year exclusive distribution agreement with a South African partner for its consumer weight-management products in South Africa...

Wed, 18/09/2019 - 07:48

OptiBiotix Health inks distribution pact in Australia, NZ with Maxum Foods

OptiBiotix Health said it had entered into a manufacturing, supply and distribution agreement with Maxum Foods for its weight management technology in Australia and New...

Mon, 12/08/2019 - 08:01

OptiBiotix Health inks license agreement with Tenshindo in Japan

OptiBiotix Health said subsidiary ProBiotix Health had signed a non-exclusive license agreement with Tenshindo for the use of Lactobacillus plantarum in cardiovascular food supplements in...

Wed, 03/07/2019 - 07:54

OptiBiotix Health inks licencing agreement with Kappa Bioscience

OptiBiotix Health said subsidiary ProBiotix Health had signed a license agreement with Kappa Bioscience.

The agreement covered the use of OptiBiotix Health's blood pressure-reducing probiotic...

Mon, 01/07/2019 - 08:51